Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lezra + Clomid vs Lezra Alone in Clomiphene Citrate Resistant PCOS
NCT06813118Phase 1Completed
- Sponsor
- HITEC Institute of Medical Sciences
- Start
- Jun 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of clomiphene in polycystic ovary syndrome (PCOS) (2 arms), sponsored by HITEC Institute of Medical Sciences. Primary endpoint: Rate of Ovulation at 6 months. Started Jun 2024; status: completed.
02
Drugs
clomiphene
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06813118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06813118.